Glioblastoma survival improved following FDA approval of bevacizumab
8/21/2013
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer...
BI-RADS 3 breast lesions found to have low cancer rate in multicenter trial
8/21/2013
Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be re-evaluated with imaging in 12 months, reducing patient anxiety, follow-up exams and unnecessary biopsies. Results of the study are published online in the journal Radiology...
Glioblastoma response to anti-angiogenesis therapy revealed by new MR analysis technique
8/20/2013
A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective...
Breast cancer specialists at Anglia Ruskin University are proposing the introduction of a new model to provide safer treatment for patients with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer...
Treatment-resistant lymphomas 'reprogrammed' to respond to cancer drugs
8/20/2013
A phase I clinical trial showed diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research...
Cancer-fighting immune activity boosted by dialing back Treg cell function in animal model
8/20/2013
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy - harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses...
Long-term side-effects in testicular cancer could be reduced by chemotherapy before radiotherapy
8/20/2013
Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports...
Twice as many people think cancer is a death sentence in the UK compared to the US
8/20/2013
The Lilly PACE initiative today launched the results of a survey of cancer patients, their carers and the general public around current perceptions of cancer care...
Multiple myeloma: link to gene involved in aging
8/19/2013
Researchers say that a gene responsible for helping to control the aging process by regulating a "cell's internal clock" may be linked to a type of blood cancer...
New boost for immune system against tumors - study
8/19/2013
Researchers have found a new way to boost the immune system's anti-tumor activity and shown it is safe in mice. They believe their findings will lead to new drugs that target the protein involved so the immune system shrinks tumors without affecting healthy tissue. Dr...